Ryan Maynard

Ryan Maynard

Director of Finance/CFO at FOGHORN THERAPEUTICS INC.
56 year
Health Technology
Technology Services
Electronic Technology

Profile

Ryan D.
Maynard
is currently an Independent Director at Iovance Biotherapeutics, Inc. since 2015 and Chief Financial & Accounting Officer at Foghorn Therapeutics, Inc. starting in 2026.
Former roles include Chief Financial Officer at CARA Therapeutics, Inc. from 2022 to 2025; Chief Financial Officer at LetsGetChecked, Inc. from 2019 to 2022; Chief Financial Officer at Blade Therapeutics, Inc. from 2018 to 2019; CFO, Executive VP & Head-Investor Relations at Rigel Pharmaceuticals, Inc. from 2011 to 2017; Controller, Director-Finance & Accounting at Personify, Inc. (California) in 2001; Controller at General Magic, Inc. from 1998 to 1999; Senior Manager-Finance at Siliconix, Inc. from 1994 to 1998; and Chief Financial Officer at Paulus.
(Holdings) Ltd. Education includes undergraduate studies at Santa Clara University.

Ryan Maynard active positions

CompaniesPositionStart
IOVANCE BIOTHERAPEUTICS, INC. Director/Board Member 16/02/2015
FOGHORN THERAPEUTICS INC. Director of Finance/CFO 23/02/2026

Former positions of Ryan Maynard

CompaniesPositionEnd
CARA THERAPEUTICS, INC. Director of Finance/CFO 01/04/2025
Director of Finance/CFO 01/03/2022
Director of Finance/CFO 01/06/2019
RIGEL PHARMACEUTICALS, INC. Director of Finance/CFO 31/12/2017
Director of Finance/CFO 01/04/2001
See the detail of Ryan Maynard's experience

Training of Ryan Maynard

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

48

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies11

Electronic Technology

Technology Services

Health Technology

Technology Services

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Technology Services

Finance

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!